Mirae Asset Global Investments
PHAT icon

Mirae Asset Global Investments’s Phathom Pharmaceuticals PHAT Stock Holding History

Mirae Asset Global Investments’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7K Sell
3,567
-543
-13% -$6.2K ﹤0.01% 1397
2026
Q1 		$45.7K Buy
4,110
+653
+19% +$8.25K ﹤0.01% 1311
2025
Q4 		$57.4K Buy
3,457
+714
+26% +$10.2K ﹤0.01% 1367
2025
Q3 		$32.3K Buy
2,743
+46
+2% +$475 ﹤0.01% 1421
2025
Q2 		$25.9K Buy
2,697
+409
+18% +$2.26K ﹤0.01% 1359
2025
Q1 		$15.1K Buy
2,288
+9
+0.4% +$55 ﹤0.01% 1419
2024
Q4 		$18.6K Sell
2,279
-191
-8% -$2.37K ﹤0.01% 1431
2024
Q3 		$43.3K Buy
2,470
+722
+41% +$10.1K ﹤0.01% 1328
2024
Q2 		$18.2K Sell
1,748
-12,158
-87% -$125K ﹤0.01% 1394
2024
Q1 		$102K Buy
13,906
+270
+2% +$2.29K ﹤0.01% 2369
2023
Q4 		$124K Buy
13,636
+95
+0.7% +$819 ﹤0.01% 2425
2023
Q3 		$140K Buy
13,541
+97
+0.7% +$1.33K ﹤0.01% 2385
2023
Q2 		$193K Buy
13,444
+210
+2% +$2.42K ﹤0.01% 2352
2023
Q1 		$94.5K Sell
13,234
-26
-0.2% -$228 ﹤0.01% 2456
2022
Q4 		$149K Buy
+13,260
New +$137K ﹤0.01% 2370
2022
Q3 		– Sell
-89,942
Closed -$6.7M – 2649
2022
Q2 		$6.7M Buy
+89,942
New +$925K 0.02% 741

Other funds holding PHAT

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Mirae Asset Global Investments's PHAT Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Phathom Pharmaceuticals (PHAT) stake by 13% in Q2 2026, selling an estimated $6.2K and leaving 3,567 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

Mirae Asset Global Investments first reported a position in PHAT in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.7M in Q2 2022. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Mirae Asset Global Investments held 3,567 shares of Phathom Pharmaceuticals worth $38.7K as of Q2 2026.
  • Mirae Asset Global Investments sold 543 Phathom Pharmaceuticals shares in Q2 2026, an estimated $6.2K.
  • Phathom Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1397 holding.
  • Mirae Asset Global Investments first reported a position in Phathom Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Phathom Pharmaceuticals position peaked at $6.7M in Q2 2022.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.